Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

AstraZeneca submitted data for vaccine approval, UK's Hancock says

1 minute read

Health Secretary Matt Hancock gestures as he speaks during a news conference at 10 Downing Street, amid the coronavirus disease (COVID-19) outbreak, in London, Britain December 10, 2020. REUTERS/Simon Dawson/Pool

LONDON, Dec 23 (Reuters) - British Health Minister Matt Hancock said on Wednesday that AstraZeneca had submitted a full data package about its COVID-19 vaccine to the medicines regulator, the next step in its journey to approval for use.

"I'm delighted to be able to tell you that the Oxford AstraZeneca vaccine developed here in the UK has submitted its full data package to the MHRA for approval," Hancock said.

"This is the next step towards a decision on the deployment of the vaccine, which is already being manufactured, including here in the UK."

Reporting by Kate Holton, writing by Michael Holden

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters